118 related articles for article (PubMed ID: 26454078)
1. Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice.
Delgado-Roche L; Brito V; Acosta E; Pérez A; Fernández JR; Hernández-Matos Y; Griñán T; Soto Y; León OS; Marleau S; Vázquez AM
Free Radic Biol Med; 2015 Dec; 89():557-66. PubMed ID: 26454078
[TBL] [Abstract][Full Text] [Related]
2. Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans.
Soto Y; Acosta E; Delgado L; Pérez A; Falcón V; Bécquer MA; Fraga Á; Brito V; Álvarez I; Griñán T; Fernández-Marrero Y; López-Requena A; Noa M; Fernández E; Vázquez AM
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):595-604. PubMed ID: 22267481
[TBL] [Abstract][Full Text] [Related]
3. The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis.
Delgado-Roche L; Acosta E; Soto Y; Hernández-Matos Y; Olivera A; Fernández-Sánchez E; Vázquez AM
Free Radic Res; 2013 Apr; 47(4):309-15. PubMed ID: 23409997
[TBL] [Abstract][Full Text] [Related]
4. Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody.
Soto Y; Mesa N; Alfonso Y; Pérez A; Batlle F; Griñán T; Pino A; Viera J; Frómeta M; Brito V; Olivera A; Zayas F; Vázquez AM
MAbs; 2014; 6(5):1340-6. PubMed ID: 25517318
[TBL] [Abstract][Full Text] [Related]
5. Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE
Sarduy R; Brito V; Castillo A; Soto Y; Griñán T; Marleau S; Vázquez AM
Front Immunol; 2017; 8():232. PubMed ID: 28316603
[TBL] [Abstract][Full Text] [Related]
6. Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.
Brito V; Mellal K; Portelance SG; Pérez A; Soto Y; deBlois D; Ong H; Marleau S; Vázquez AM
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2847-54. PubMed ID: 23087361
[TBL] [Abstract][Full Text] [Related]
7. Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.
Brito V; Mellal K; Zoccal KF; Soto Y; Ménard L; Sarduy R; Faccioli LH; Ong H; Vázquez AM; Marleau S
Front Pharmacol; 2017; 8():782. PubMed ID: 29163168
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
11. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
12. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
16. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
[TBL] [Abstract][Full Text] [Related]
17. Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.
Tibolla G; Norata GD; Meda C; Arnaboldi L; Uboldi P; Piazza F; Ferrarese C; Corsini A; Maggi A; Vegeto E; Catapano AL
Atherosclerosis; 2010 May; 210(1):78-87. PubMed ID: 19945109
[TBL] [Abstract][Full Text] [Related]
18. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
19. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.
Kato R; Mori C; Kitazato K; Arata S; Obama T; Mori M; Takahashi K; Aiuchi T; Takano T; Itabe H
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):33-9. PubMed ID: 18988894
[TBL] [Abstract][Full Text] [Related]
20. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
Burger-Kentischer A; Göbel H; Kleemann R; Zernecke A; Bucala R; Leng L; Finkelmeier D; Geiger G; Schaefer HE; Schober A; Weber C; Brunner H; Rütten H; Ihling C; Bernhagen J
Atherosclerosis; 2006 Jan; 184(1):28-38. PubMed ID: 15921687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
